Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ferrandiz

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Actas Dermo-Sifiliograficas|September 23, 2010
[Guidelines on the use of methotrexate in psoriasis]G Carretero, L Puig, L Dehesa, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 5, 2014
Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registryC Medina, G Carretero, C Ferrandiz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 2, 2014
Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registryG Carretero, C Ferrandiz, E Dauden, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 23, 2016
Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysisP Dávila-Seijo, E Dauden, G Carretero, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 3, 2017
Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registryA Pérez-Plaza, G Carretero, C Ferrandiz, et al.
The British Journal of Dermatology|July 22, 2004
Biological therapies in the systemic management of psoriasis: International Consensus ConferenceW Sterry, J Barker, W-H Boehncke, et al.
Actas Dermo-Sifiliograficas|April 23, 2023
Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre StudyO M Moreno-Arrones, S Béa-Ardebol, F Mayo-Martinez, et al.
Actas Dermo-Sifiliograficas|June 11, 2023
Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre StudyO M Moreno-Arrones, S Béa-Ardebol, F Mayo-Martinez, et al.
Actas Dermo-Sifiliograficas|September 24, 2016
Management of Biologic Therapy in Moderate to Severe Psoriasis in Surgical Patients: Data From the Spanish Biobadaderm RegistryS Galiano Mejías, G Carretero, C Ferrandiz, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 13, 2008
Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 casesR N Matin, D Mesher, C M Proby, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Actas Dermo-Sifiliograficas|September 23, 2010
[Guidelines on the use of methotrexate in psoriasis]G Carretero, L Puig, L Dehesa, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 5, 2014
Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registryC Medina, G Carretero, C Ferrandiz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 2, 2014
Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registryG Carretero, C Ferrandiz, E Dauden, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 23, 2016
Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysisP Dávila-Seijo, E Dauden, G Carretero, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 3, 2017
Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registryA Pérez-Plaza, G Carretero, C Ferrandiz, et al.
The British Journal of Dermatology|July 22, 2004
Biological therapies in the systemic management of psoriasis: International Consensus ConferenceW Sterry, J Barker, W-H Boehncke, et al.
Actas Dermo-Sifiliograficas|April 23, 2023
Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre StudyO M Moreno-Arrones, S Béa-Ardebol, F Mayo-Martinez, et al.
Actas Dermo-Sifiliograficas|June 11, 2023
Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre StudyO M Moreno-Arrones, S Béa-Ardebol, F Mayo-Martinez, et al.
Actas Dermo-Sifiliograficas|September 24, 2016
Management of Biologic Therapy in Moderate to Severe Psoriasis in Surgical Patients: Data From the Spanish Biobadaderm RegistryS Galiano Mejías, G Carretero, C Ferrandiz, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 13, 2008
Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 casesR N Matin, D Mesher, C M Proby, et al.
Pageof 5